About Us
We are developing potentially best in class therapies for patients living with severe autoimmune diseases. Our lead antibody, claseprubart (DNTH103), is purposefully engineered with extended half-life, improved potency, and high selectivity for only the active C1s complement protein that drives disease pathology – enabling less frequent and more convenient self-administered subcutaneous injections. Our second clinical candidate, DNTH212 is a first and potentially best in class, bifunctional inhibitor that targets clinically validated and complementary disease modifying mechanisms, Type 1 IFN suppression and B cell modulation – enabling potential for improved clinical outcomes and patient friendly convenient, self-administered subcutaneous injections. To learn more, please visit www.dianthustx.com and follow us on LinkedIn
About the Role
The Associate Director, Regulatory CMC, will execute global regulatory CMC strategies in collaboration with key stakeholders.
Reporting to the Vice President, Regulatory CMC, you will provide expert guidance to manufacturing and quality teams, lead global regulatory submissions, act as primary liaison with Health Authorities for CMC aspects of programs, and interpret applicable EMA/FDA/ICH/WHO/Global regulations to ensure CMC compliance, and contribute to department initiatives. You must have experience with biologics, specifically monoclonal antibodies, bispecifics, and / or fusion proteins or vaccines in order to be successful in this role.
This is a unique opportunity to join a growing organization with an expanding pipeline and play an integral role in the creation and implementation of regulatory strategies from early development through marketing approval. We are building a culture of individuals who hold our core principles at the center of our operations, with the goal to elevate the care of our patients’ lives. We are open to you working remotely.
Key Responsibilities
Experience

Dianthus Therapeutics, Inc. is a clinical-stage biotechnology company dedicated to developing next-generation therapies to transform the treatment of severe autoimmune diseases. Based in New York City and Waltham, Mass., Dianthus is comprised of an experienced team of biotech and pharma executives who aim to deliver transformative medicines for people living with severe autoimmune and inflammatory diseases.